-income countries in sub-Saharan Africa and Some upper-middle-income countries, as well as countries that have transitioned from lower-middle-income status to upper-middle-income status in the past five years, do not cover the Chinese market
pharmaceutical companies. What is unique about this cutting-edge protein degradation agent?
Time of Update: 2022-05-26
Image source: Amphista's official website In cooperation with Merck, Germany, the two companies will develop small-molecule protein degraders for 3 targets in the fields of oncology and immunology .
China's over 100 billion pharmaceutical companies
Time of Update: 2022-05-26
Industrial chain extension: integration and sharing platform Sinopharm Holding, Shanghai Pharmaceuticals and China Resources Pharma, represented by state-owned holdings, have adopted a strategic layout of upstream and downstream integration, but the focus of the companies is different .
The salaries of executives of eleven listed instrument companies in 2021 are "exposed"
Time of Update: 2022-05-25
1572 million yuan from the company, director and general manager Zhang Yan received a total pre-tax remuneration of 1.
WuXi AppTec was named "2022 ESG Industry's Highest Rated Company" by Sustainalytics
Time of Update: 2022-05-25
62em; font-family:"Arial"; color:black; margin:0in; } SHANGHAI, April 8, 2022 /PRNewswire/ -- Recently, WuXi AppTec was awarded the "2022 ESG (Environmental, Social and Governance) Industry's Highest Rating Enterprise" by Sustainalytics, a well-known international rating agency .
companies take the road of household ultrasonic gas meters?
Time of Update: 2022-05-25
of the ultrasonication of small-caliber civil gas meters is concerned, we are still in the initial stage of development . Similar to the law of development of many industries, in the subdivision
The CTLA-4, PD-1 track is crowded, and the development of the next generation of tumor immunotherapy is a new target for drug companies
Time of Update: 2022-05-24
Under the current fierce competition on the track, developing the next generation of tumor immunotherapy is becoming the goal of some pharmaceutical companies and researchers .
Baiji Baiji, Nuocheng Jianhua, Hengrui and other pharmaceutical companies enter the tens of billions of BTK inhibitor market
Time of Update: 2022-05-24
According to relevant data analysis, the global market for BTK inhibitors is growing rapidly and is expected to reach US$11.
In order to adjust the development layout, domestic pharmaceutical companies are accelerating "slimming"
Time of Update: 2022-05-24
It is worth mentioning that on March 9, Ruizhi Pharmaceutical also issued an announcement on the sale of assets, saying that it planned to sell 100% equity of its wholly-owned subsidiary Kaihui Pharmaceutical (Shanghai) Co.
Overweighting the best-selling anti-virus variety, Sunshine Pharmaceuticals grabs the second domestic company
Time of Update: 2022-05-24
Figure 1: Approval of Oseltamivir Phosphate Dry Suspension Source: NMPA official website Table 1: TOP5 varieties of systemic antiviral drugs in 2021E retail market Source: Minet.
In the first quarter, over 90 domestic biopharmaceutical companies completed financing
Time of Update: 2022-05-24
Analysts said that in the first quarter of 2022, the total scale of investment and financing in the medical and health field was relatively stable, and the number of investment and financing events and the amount involved increased .
Multi-pharmaceutical companies signed overseas licensing agreements to accelerate international market layout
Time of Update: 2022-05-24
On the morning of April 7, Harbin Pharmaceutical announced that it has entered into a global external licensing agreement with AstraZeneca to develop and commercialize HBM7022 .
Since March, pharmaceutical biology is still a hot research field for institutions, and these pharmaceutical companies have received high attention
Time of Update: 2022-05-23
the company's product layout . In terms of Kinsey's follow-up products, the company will accelerate the research and development and sales of children's nutrition, new indications for adult growth
pharmaceutical machine companies have attracted the attention of securities companies
Time of Update: 2022-05-23
The industry expects that the independent and controllable biopharmaceutical supply chain will become a major trend, and the leading pharmaceutical machine companies are expected to benefit in this context .
Suzhou Goodtech plans to increase its capital by US$2 million in AICS, a subsidiary company in Malaysia
Time of Update: 2022-05-23
/>. After the completion of this capital increase, Goodtech Electronic Technology will still be a wholly-owned subsidiary of the company, and AICS will still be a wholly-owned subsidiary of Goodtech Electronic Technology
The average R&D investment of domestic pharmaceutical companies has increased, and innovation is pressing the "acceleration button"!
Time of Update: 2022-05-23
A number of pharmaceutical companies will invest more than 1 billion yuan in research and development in 2021 .
Last month, domestic biopharmaceutical companies reached 6 license-in transactions
Time of Update: 2022-05-23
terms . It is understood that in the past March, domestic biopharmaceutical companies disclosed a number of license-in transactions covering tumor, respiratory system and other fields
